Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling |
| |
Authors: | Yutong Zhao Viswanathan Natarajan |
| |
Institution: | 1. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA;2. Department of Pharmacology, University of Illinois at Chicago, Chicago, IL, USA;3. Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA;4. Institute for Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, IL, USA |
| |
Abstract: | Lysophosphatidic acid (LPA), a simple bioactive phospholipid, is present in biological fluids such as plasma and bronchoalveolar lavage (BAL). It appears to have both pro- and anti-inflammatory roles in inflammatory lung diseases. Exogenous LPA promotes inflammatory responses by regulating the expression of chemokines, cytokines, and cytokine receptors in lung epithelial cells. In addition to the modulation of inflammatory responses, LPA regulates cytoskeleton rearrangement and confers protection against lung injury by enhancing lung epithelial cell barrier integrity and remodeling. The biological effects of LPA are mediated through its cell surface G-protein coupled LPA1–7 receptors. The roles of LPA receptors in lung fibrosis, asthma, and acute lung injury have been investigated using genetically engineered LPA receptor deficient mice and there appears to be a definitive role for endogenous LPA and its receptors in the pathogenesis of pulmonary inflammatory diseases. This review summarizes recent reports on the role of LPA and its receptors in the regulation of lung epithelial inflammatory responses and remodeling. This article is part of a Special Issue entitled: Advances in Lysophospholipid Research. |
| |
Keywords: | Lysophosphatidic acid (LPA) LPA receptor Lung epithelial cell Cytokine Cell motility Lung inflammatory disease |
本文献已被 ScienceDirect 等数据库收录! |
|